# Enspectra Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/enspectra-health

- Industry: Medical Devices & Equipment
- Headquarters: Mountain View, US
- Website: www.enspectrahealth.com
- Total disclosed funding: $7.3M
- Latest round: Series A (Feb 21, 2019)
- Investors on record: 1

## About

Enspectra Health, Inc. specializes in innovative imaging solutions for dermatology, utilizing advanced technology to provide non-invasive assessments of skin conditions, thereby enhancing patient care and treatment options.Founded in 2014 and headquartered in Mountain View, US, Enspectra Health, Inc. is dedicated to developing state-of-the-art imaging solutions for dermatological applications. The company has completed a total of 3 deals, with the most recent funding event occurring on July 19, 2023, where it raised USD 2.00 mn in a GRANT round from Small Business Innovation Research. The total amount raised by the company is USD 7.35 mn. Gabriel Sanchez is both the founder and CEO of the company.Enspectra Health focuses on innovative imaging solutions for dermatology, primarily through its flagship product, the VIO system. This advanced skin imaging technology utilizes a combination of multiphoton laser scanning and reflectance confocal microscopy to produce high-resolution digital images of live skin cells without the need for invasive procedures. The VIO system enables dermatologists and healthcare providers to assess a wide range of skin conditions in real time and provide actionable insights to patients. Enspectra Health's products target markets across North America, Europe, and Asia, catering to healthcare facilities, dermatology practices, and research institutions seeking to enhance skin health evaluations.Enspectra Health operates on a business model that includes direct sales to healthcare providers and dermatology practices, along with potential partnerships with medical institutions. The company's revenue generation is primarily driven by the sales of its VIO skin imaging system, which may be offered through various pricing structures that encourage adoption among healthcare professionals. Additionally, Enspectra may engage in service agreements or subscription models for software updates and AI-powered analytics, ensuring continuous support and the latest technological advancements for its clients, focusing on leveraging advanced imaging technology to meet the needs of a growing client base in the dermatology sector.In July 2023, Enspectra Health, Inc. raised USD 2 million in grant funding from new investor Small Business Innovation Research. This funding will be utilized to develop deep-learning algorithms, enhancing the capabilities of its imaging technologies. The company is focused on launching new products that incorporate these advanced algorithms, with plans to enrich the functionality of the VIO system. Furthermore, Enspectra Health is looking to expand into new markets in Europe and Asia by the end of 2024, further broadening its reach within the dermatology field.

## Funding rounds

- Series A, Feb 21, 2019, $7.3M — Foothill Ventures

## Investors

- Foothill Ventures (https://capitalatlas.ai/funds/foothill-ventures) — Series A